Z17.421 is a billable/specific and POA-exempt diagnosis code from the 2026 ICD-10-CM used to classify the following condition: Hormone receptor negative with human epidermal growth factor receptor 2 negative status.
Inclusion term
HR- with HER2-
TNBC
Triple negative breast cancer
Versions
2026
No changes
2025
New code